Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
98 | 3 | STATINS//JOURNAL OF LIPID RESEARCH//LIPOPROTEINS | 77402 |
373 | 2 | STATINS//EZETIMIBE//SIMVASTATIN | 17683 |
4327 | 1 | STATINS//HMG COA REDUCTASE INHIBITORS//SIMVASTATIN | 1838 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | STATINS | authKW | 834273 | 33% | 8% | 611 |
2 | HMG COA REDUCTASE INHIBITORS | authKW | 268335 | 7% | 12% | 128 |
3 | SIMVASTATIN | authKW | 255433 | 10% | 8% | 180 |
4 | FLUVASTATIN | authKW | 177876 | 4% | 16% | 65 |
5 | ATORVASTATIN | authKW | 134653 | 7% | 6% | 122 |
6 | PLEIOTROPIC EFFECTS | authKW | 105975 | 2% | 14% | 44 |
7 | 3 HYDROXY 3 METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS | authKW | 89115 | 1% | 20% | 26 |
8 | PRAVASTATIN | authKW | 82636 | 3% | 8% | 61 |
9 | CERIVASTATIN | authKW | 61201 | 1% | 18% | 20 |
10 | HMG COA REDUCTASE INHIBITION | authKW | 40630 | 0% | 30% | 8 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 6468 | 18% | 0% | 327 |
2 | Cardiac & Cardiovascular System | 5616 | 22% | 0% | 412 |
3 | Pharmacology & Pharmacy | 2858 | 25% | 0% | 451 |
4 | Hematology | 931 | 8% | 0% | 139 |
5 | Critical Care Medicine | 683 | 4% | 0% | 75 |
6 | Respiratory System | 566 | 5% | 0% | 95 |
7 | Immunology | 424 | 9% | 0% | 165 |
8 | Medicine, Research & Experimental | 361 | 6% | 0% | 118 |
9 | Medicine, General & Internal | 141 | 6% | 0% | 106 |
10 | Physiology | 117 | 4% | 0% | 69 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EMI 99 12 | 34291 | 0% | 100% | 2 |
2 | EXCELLENCE NOREG SAS | 34291 | 0% | 100% | 2 |
3 | P DIS TB INTERNAL MED | 22859 | 0% | 67% | 2 |
4 | ALBERT SZENT GYO RGYI MED | 17146 | 0% | 100% | 1 |
5 | ANESTHESIOL MULTIDISCIPLINARY EPIDEMIOL TR | 17146 | 0% | 100% | 1 |
6 | AREA NEUROCIENCIOS IDIPAZ | 17146 | 0% | 100% | 1 |
7 | ASSOCIATE INTERNAL MED IDENCY PROGRAM | 17146 | 0% | 100% | 1 |
8 | ATHERIOCLEROSIS LIPID DISORDERS | 17146 | 0% | 100% | 1 |
9 | BASIC MED SCI HISTOL EMBRIOL | 17146 | 0% | 100% | 1 |
10 | BASIC PHYSIOL PHARMACOL | 17146 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS | 6406 | 3% | 1% | 64 |
2 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 4695 | 3% | 1% | 46 |
3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2937 | 2% | 0% | 44 |
4 | CURRENT MOLECULAR PHARMACOLOGY | 2750 | 0% | 5% | 3 |
5 | CURRENT OPINION IN LIPIDOLOGY | 1234 | 1% | 1% | 10 |
6 | CARDIOVASCULAR DRUGS AND THERAPY | 1233 | 1% | 1% | 12 |
7 | CIRCULATION | 1111 | 2% | 0% | 41 |
8 | VASCULAR PHARMACOLOGY | 934 | 0% | 1% | 8 |
9 | PHARMACOLOGICAL RESEARCH | 886 | 1% | 0% | 15 |
10 | PULMONARY PHARMACOLOGY & THERAPEUTICS | 884 | 0% | 1% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |